New Experimental Model of Allergic Rhinitis of Rat
Zhong Chen
Abstract
Zhong Chen
Abstract
Objective: To develop an experimental animal model of allergic rhinitis in rats. Methods: Generally sensitized rats were received repeated local booster sensitization into nasal cavity. The severity of allergic rhinitis was determined by two nasal allergic symptoms (sneezing and nasal rubbing), and the levels of IgE were assessed by PCA titers. Results: The numbers of sneezing and nasal rubbing were markedly increased and at the meantime, the levels of IgE were also markedly elevated by intranasal sensitization. Ketotifen and astemizole inhibited significantly the antigen induced nasal symptoms with a dose dependent mode. Conclusion: The allergic rhinitis model is very useful for evaluating the effects of drugs for Ⅰ type allergic rhinitis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To develop an experimental animal model of allergic rhinitis in rats. Methods: Generally sensitized rats were received repeated local booster sensitization into nasal cavity. The severity of allergic rhinitis was determined by two nasal allergic symptoms (sneezing and nasal rubbing), and the levels of IgE were assessed by PCA titers. Results: The numbers of sneezing and nasal rubbing were markedly increased and at the meantime, the levels of IgE were also markedly elevated by intranasal sensitization. Ketotifen and astemizole inhibited significantly the antigen induced nasal symptoms with a dose dependent mode. Conclusion: The allergic rhinitis model is very useful for evaluating the effects of drugs for Ⅰ type allergic rhinitis.
Key concepts: Astemizole, Medicine, Sensitization, Ketotifen, Immunology, Nasal cavity, Nasal administration, Immunoglobulin E